Comparison of the Binding of 3-Fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with Their Isosteric Sulfonamides to the Active Site of Phenylethanolamine N-Methyltransferase1

publication · 10 years ago
by Gary L. Grunewald, Mitchell R. Seim, Kevin R. Criscione, Rachel C. Regier, Jennifer L. Martin, Christine L. Gee, Nyssa Drinkwater (University of Kansas)
Calculator Plugins (logP logD pKa etc...)
3-Fluoromethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines (14, 16, and 18−22) are highly potent and selective inhibitors of phenylethanolamine N-methyltransferase (PNMT). Molecular modeling studies with 3-fluoromethyl-7-(N-alkyl aminosulfonyl)-1,2,3,4-tetrahydroisoquinolines, such as 16, suggested that the sulfonamide −NH− could form a hydrogen bond with the side chain of Lys57. However, SAR studies and analysis of the crystal structure of human PNMT (hPNMT) in complex with 7 indicated that the sulfonamide oxygens, and not the sulfonamide −NH−, formed favorable interactions with the enzyme. Thus, we hypothesized that replacement of the sulfonamide −NH− with a methylene group could result in compounds that would retain potency at PNMT and that would have increased lipophilicity, thus increasing the likelihood they will cross the blood brain barrier. A series of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines (23−30) were synthesized and evaluated for their PNMT inhibitory potency and affinity for the α2-adrenoceptor. A comparison of these compounds with their isosteric sulfonamides (14, 16, and 18−22) showed that the sulfones were more lipophilic but less potent than their corresponding sulfonamides. Sulfone 24 (hPNMT Ki = 1.3 μM) is the most potent compound in this series and is quite selective for PNMT versus the α2-adrenoceptor, but 24 is less potent than the corresponding sulfonamide, 16 (hPNMT Ki = 0.13 μM). We also report the crystal structure of hPNMT in complex with sulfonamide 15, from which a potential hydrogen bond acceptor within the hPNMT active site has been identified, the main chain carbonyl oxygen of Asn39. The interaction of this residue with the sulfonamide −NH− is likely responsible for much of the enhanced inhibitory potency of the sulfonamides versus the sulfones.
Visit publication